Old National Bancorp (ONB) vs Translational Development Acquisition Corp. (TDAC)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| ONB | TDAC | |
|---|---|---|
| Sector | Financial Services | Financial Services |
| Industry | Banks - Regional | Shell Companies |
| Size band | MID | SMALL |
| Listing | Nasdaq GS | Nasdaq GM |
| Country | United States | United States |
| Theme | regional-banks | ev-batteries |
| Price and returns | ||
| Last close | $25.03 | $10.85 |
| Return · 1 week | +1.01% | +0.37% |
| Return · 1 month | −0.71% | 0.00% |
| Return · 3 months | −6.92% | +0.09% |
| Return · year to date | +11.69% | +3.43% |
| Return · 1 year | +21.90% | +4.03% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −8.52% | −0.91% |
| 52-week high | $27.36 | $10.95 |
| 52-week low | $19.60 | $10.40 |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $9.48B | $209.50M |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $87.90M | $86.26K |
| Employees | 4,894 | — |
| Valuation | ||
| Price to earnings · trailing | 10.29× | 41.64× |
| Price to earnings · forward | 8.98× | — |
| Price to sales | 3.60× | — |
| Price to book | 1.16× | n/a (negative book value) |
| Enterprise value to revenue | 6.19× | — |
| PEG ratio | 1.59 | — |
| Earnings per share · trailing | 2.46 | 0.26 |
| Profitability | ||
| Operating margin | 53.70% | 0.00% |
| Profit margin | 35.39% | — |
| Return on equity | 11.54% | — |
| Return on assets | 1.32% | −0.49% |
| Growth | ||
| Revenue growth | 0.00% | — |
| Earnings growth | +43.60% | −40.60% |
| Balance sheet and payout | ||
| Current ratio | — | 0.06 |
| Dividend yield | 2.29% | 0.00% |
| Payout ratio | 25.22% | 0.00% |
| Trend and volatility | ||
| RSI · 14 | 49.70 | 44.23 |
| ADX · 14 | 20.52 | 39.96 |
| 50-day average | $25.33 | $10.84 |
| 200-day average | $24.58 | $10.69 |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 2.26% | 0.37% |
The full ONB analysis
Everything this table leaves out for Old National Bancorp: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the ONB argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full ONB analysisThe full TDAC analysis
Everything this table leaves out for Translational Development Acquisition Corp.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the TDAC argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full TDAC analysis